Permeability of rhynchophylline across human intestinal cell in vitro

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 1957-1966

  Ma, Bo ^a   Wang, Jing ^a   Sun, Jing ^a   Li, Ming ^a   Xu, Huibo ^b   Sun, Guibo ^a   Sun, Xiaobo ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Caco 2 cells; P glycoprotein; Permeability; Rhynchophylline

Indexed keywords

ABCB1 PROTEIN, HUMAN; HERBACEOUS AGENT; INDOLE ALKALOID; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123; RHYNCOPHYLLINE; VERAPAMIL;

CACO 2 CELL LINE; CELL SURVIVAL; DRUG EFFECTS; HUMAN; IMPEDANCE; INTESTINE; INTESTINE ABSORPTION; KINETICS; METABOLISM; PERMEABILITY; UPREGULATION;

CACO-2 CELLS; CELL SURVIVAL; DRUGS, CHINESE HERBAL; ELECTRIC IMPEDANCE; HUMANS; INDOLE ALKALOIDS; INTESTINAL ABSORPTION; INTESTINES; KINETICS; P-GLYCOPROTEINS; PERMEABILITY; RHODAMINE 123; UP-REGULATION; VERAPAMIL;

EID: 84902486196     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Laus G, Teppner H. The alkaloids of Uncaria rhynchophylla (Rubiaceae-Coposapelteae). Phyton (Austria) 1996; 36: 185-196.
2. Zhixian Mo, Dandan Xu. New clinical research progress of Uncaria rhynchophylla. Lishizhen Medicine and Materia Medica Research 2006; 17: 684-685.
3. Zhou JY, Zhou SW. Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. J Ethnopharmacol 2010; 132: 15-27.
4. Zhang WB, Chen CX, Sim SM, Kwan CY. In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel). Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 232-238.
5. Chou CH, Gong CL, Chao CC, Lin CH, Kwan CY, Hsieh CL, Leung YM. Rhynchophylline from Uncaria rhynchophylla Functionally turns delayed rectifiers into A-Type K+ Channels. J Nat Prod 2009; 72: 830-834.
6. Hsieh CL, Ho TY, Su SY, Lo WY, Liu CH, Tang NY. Uncaria rhynchophylla and Rhynchophylline inhibit c-Jun N-Terminal Kinase Phosphorylation and Nuclear Factor-κB Activity in Kainic Acid-Treated Rats. Am J Chn Med 2009; 37: 351-360.
7. Liu JY, Lee KF, Sze CW, Tong Y, Tang SC, Ng TB, Zhang YB. Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control. J Pharm Pharmacol 2012; 65: 621-633.
8. Netzel M, Netzel G, Zabaras D, Lundin L, Day L, Addepalli R, Osborne SA, Seymour R. Release and absorption of carotenes from processed carrots (Daucus carota) using in vitro digestion coupled with a Caco-2 cell trans-well culture model. Food Res Int 2011; 44: 868-874.
9. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001; 46: 27-43.
10. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009; 323: 1718-1722.
11. Watts T, Berti I, Sapone A, Gerarduzzi T, Not T, Zielke R, Fasano A. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005; 102: 2916-2921.
12. Ibrahim S, Peggins J, Knapton A, Licht T, Aszalos A. Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin:P-glycoprotein modulation. J Pharmacol Exp Ther 2000; 295: 1276-83.
13. Kang TH, Murakami Y, Takayama H, Kitajima M, Aimi N, Watanabe H, Matsumoto K. Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. Life Sci 2004; 76: 331-343.
14. Li PY, Zeng XR, Cheng J, Wen J, Inoue I, Yang Y. Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells. Naunyn-Schmiedeberg's Arch Pharmacol 2013; 386: 973-982.
15. Wang W, Ma CM, Hattori M. Metabolism and pharmacokinetics of Rhynchophyline in rats. Biol Pharm Bull 2012; 33: 669-676.
16. Isshiki M, Umezawa K, Tamura H. Coffee induces breast cancer resistance protein expression in Caco-2 cells. Biol Pharm Bull 2011; 34: 1624-1627.
17. Ma B, Sun GB, Xu HB, Li M, Yang ZH and Sun XB. Rhynchophylline in rat blood by high-performance liquid chromatography-coupled microdialysis. J Med Plants Res 2012; 6: 2977-2984.
18. Uchida M, Fukazawa T, Yamazaki Y, Hashimoto H, Miyamoto Y. A modified fast (4 day) 96-well plate Caco-2 permeability assay. J Pharmacol Toxicol 2009; 59: 39-43.
19. Yasuno T, Okamoto H, Nagai M, Kimura S, Yamamoto T, Nagano K, et al. Biol Pharm Bull 2012; 35: 588-593.
20. Wright JA, Haslam IS, Coleman T, Simmons NL. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers. Eur J Pharmacol 2011; 672: 70-76.
21. Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 2009; 292: 265-270.
22. Iwanaga K, Yoneda S, Hamahata Y, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M. Inhibitory Effects of Furanocoumarin Derivatives in Kampo Extract Medicines on P-Glycoprotein at the Blood-Brain Barrier. Biol Pharm Bull 2011; 34: 1246-1251.
23. Ma B, Sun GB, Yang ZH, Li M, Sun XB. Comparative study on different culture conditions for caco-2 cell model. Chinese Journal of Experimental Traditional Medical Formulae 2011; 17: 205-210.
24. Zhao SS, Yuan L, Wang JC, Zhang X, He ZG, Zhang Q. A novel and facile approach to imaging nanoparticles transport across transwell filter grown cell monolayer in real-time and in situ under confocal laser scanning microscopy. Biol Pharm Bull 2012; 35: 335-345.
25. Hou XL, Takahashi K, Kinoshita N, Qiu F, Tanaka K, Komatsu K, Takahashi K, Azuma J. Possible inhibitory mechanism of curcuma drugs on CYP3A4 in 1,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 2007; 337: 169-177.
26. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011; 77: 275-282.
27. Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M. Changes in the localization of lleal P-glycoprotein induced by intestinal ischemia/reperfusion. Biol Pharm Bull 2011; 34: 408-414.
28. Ishibashi M, Arai M, Tanaka S, Onda K, Hirano T. Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. Biol Pharm Bull 2012; 35: 10-17.
29. Bergstrom CAS, Bolin S, Artursson P, Ronn R, Sandstrom A. Hepatitis C virus NS3 protease inhibitors: large, flexible molecules of peptide origin show satisfactory permeability across Caco-2 cells. Eur J Pharm Sci 2009; 38: 556-563.
30. Tang FX, Ouyang H, Yang JZ, Borchardt RT. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. J Pharm Sci 2004; 93: 1185-1194.
31. Granzotto M, Drigo I, Candussio L, Rosati A, Bartoli F, Giraldi T, Decorti G. Rifampicin and verapamil induce the expression of P-glycopretein in vivo in Ehrlich ascites tumor cells. Cancer Lett 2004; 205: 107-115.
32. Yin J, Meng Q, Dong XM. Auto-inhibition of verapamil metabolism in rat hepatocytes of gel entrapment culture. Biomed Pharmacother 2011; 65: 328-333.